These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6964816)

  • 1. Constitutive gene expression and restoration of the normal phenotype in malignant cells: a model for the origin and evolution of leukemia.
    Sachs L
    Blood Cells; 1981; 7(1):31-44. PubMed ID: 6964816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of normal differentiation and restoration of the normal phenotype in leukemia.
    Sachs L
    Natl Cancer Inst Monogr; 1982; 60():221-7. PubMed ID: 6981773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: a model for the origin and progression of malignancy.
    Sachs L
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6152-6. PubMed ID: 6934543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell differentiation and malignancy.
    Sachs L
    Cell Biophys; 1986 Dec; 9(1-2):225-42. PubMed ID: 2436796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program.
    Svedberg H; Chylicki K; Baldetorp B; Rauscher FJ; Gullberg U
    Oncogene; 1998 Feb; 16(7):925-32. PubMed ID: 9484784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular and molecular environment in leukemia.
    Sachs L
    Blood Cells; 1993; 19(3):709-26; discussion 727-30. PubMed ID: 8018951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of growth and normal differentiation in leukemic cells: regulation of the developmental program and restoration of the normal phenotype in myeloid leukemia.
    Sachs L
    J Cell Physiol Suppl; 1982; 1():151-64. PubMed ID: 7040418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer genetics and cancer suppression.
    Sachs L
    Cancer Detect Prev; 1990; 14(5):539-45. PubMed ID: 2224918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulators of normal development and tumor suppression.
    Sachs L
    Int J Dev Biol; 1993 Mar; 37(1):51-9. PubMed ID: 8507571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
    Gallagher AP; Burnett AK; Bowen DT; Darley RL
    Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple changes in gene expression are associated with normal cell-induced modulation of the neoplastic phenotype.
    Chang GW; Terzaghi-Howe M
    Cancer Res; 1998 Oct; 58(19):4445-52. PubMed ID: 9766677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor-1alpha-induced differentiation of myeloid leukemic cells is its transcriptional activity independent.
    Song LP; Zhang J; Wu SF; Huang Y; Zhao Q; Cao JP; Wu YL; Wang LS; Chen GQ
    Oncogene; 2008 Jan; 27(4):519-27. PubMed ID: 17637739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new concept: treatment using differentiation of the malignant cell in man].
    Degos L
    Bull Acad Natl Med; 1995 Nov; 179(8):1689-700. PubMed ID: 8717185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
    Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
    Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
    Hoffman B; Amanullah A; Shafarenko M; Liebermann DA
    Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation.
    Taipale J; Matikainen S; Hurme M; Keski-Oja J
    Cell Growth Differ; 1994 Dec; 5(12):1309-19. PubMed ID: 7696179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
    Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis.
    Strathdee G; Holyoake TL; Sim A; Parker A; Oscier DG; Melo JV; Meyer S; Eden T; Dickinson AM; Mountford JC; Jorgensen HG; Soutar R; Brown R
    Clin Cancer Res; 2007 Sep; 13(17):5048-55. PubMed ID: 17785556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFI 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines.
    Dawson MJ; Trapani JA
    J Cell Biochem; 1995 Jan; 57(1):39-51. PubMed ID: 7536752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.